Tag: BioNTech

Investor focus is firmly on BioNTech as the biotech firm prepares to release its full-year 2025 financial results this coming ...

Investors are preparing for a significant week for BioNTech SE, with the release of its full-year 2025 financial results set ...

The equity of German biotechnology firm BioNTech is navigating a period of significant volatility. As the company accelerates its strategic ...

Investors are bracing for a pivotal week from BioNTech SE, as the biotech firm contends with a significant technical breakdown ...

The company that became a household name during the global health crisis is now executing a deliberate and fundamental strategic ...

A significant regulatory milestone has been achieved by BioNTech in the United States, providing fresh impetus for one of its ...

Shares of BioNTech advanced significantly on Friday following an upgrade from Goldman Sachs. The US investment bank now views the ...

BioNTech is fundamentally realigning its business model, shifting focus from the extraordinary COVID-19 period to a clear strategic emphasis on ...

BioNTech is executing a deliberate strategy to evolve beyond its identity as a COVID-19 vaccine specialist and refocus on its ...

Investors demonstrated notable composure as news broke of a significant patent lawsuit against BioNTech. The German biotech firm, alongside its ...